Clinical Trial Update: 68Ga PSMA 11 PET/MRI and 68Ga RM2 PET/MRI for Biopsy Guidance in Patients With Suspected Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating 68Ga PSMA-11 PET/MRI and 68Ga RM2 PET/MRI for biopsy guidance in suspected prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• 68Ga-PSMA-11 (Gallium-68 labeled PSMA-11 radiopharmaceutical)
• 68Ga-RM2

Snippet

Sponsor: Andrei Iagaru | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2024-01-11